References
- Bond M., Elston J., Mealing S., Anderson R., Weiner G., Taylor R, Stein K. 2010. Systematic reviews of the effectiveness and cost-effectiveness of multi-channel unilateral cochlear implants for adults. Clinical Otolaryngology, 35(2): 87–96.
- Brady R., Schiffmann R. 2000. Clinical features of and recent advances in therapy for Fabry disease. JAMA, 284(21): 2771–2775.
- Brouns R., Thijs V., Eyskens F., Broeck M.V.D., Belachew S., Broeckhoven C.V., et al. 2010. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. Stroke, 41(5): 863–868.
- Conti G., Sergi B. 2003. Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females. Acta Paediatrica (Oslo, Norway: 1992) 92(443) (Suppl): 33–37.
- Germain D., Avan P., Chassaing A., Bonfils P. 2002. Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Medical Genetics, 3(1): 10.
- Hajioff D., Enever Y., Quiney R., Zuckerman J., Mackermot K., Mehta A. 2003. Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy. Journal of Inherited Metabolic Disease, 26(8): 787–794.
- Hegemann S., Hajioff D., Conti G., Beck M., Sunder-Plassmann G., Widmer U., Mehta A., Keilmann A. 2006. Hearing loss in Fabry disease: data from the Fabry outcome survey. European Journal of Clinical Investigation, 36(9): 654–662.
- Low M., Nicholls K., Tubridy N., Hand P., Velakoulis D., Kiers L., Mitchell P., Becker G. 2007. Neurology of Fabry disease. Internal Medicine Journal, 37(7): 436–447.
- Masson C., Ciss'e I., Simon V., Insalaco P., Audran M. 2004. Fabry disease: a review. Joint Bone Spine, 71(5): 381–383.
- Nadol J.B., Young Y.S., Glynn R.J. 1989. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. The Annals of Otology, Rhinology, and Laryngology, 98(6): 411–416.
- Pastores G.M., Thadhani R. 2001. Enzyme-replacement therapy for Anderson–Fabry disease. Lancet, 358(9282): 601–603.
- Pastores G.M., Thadhani R. 2002. Advances in the management of Anderson–Fabry disease: enzyme replacement therapy. Expert Opinion on Biological Therapy, 2(3): 325–333.
- Schachern P.A., Shea D.A., Paparella M.M., Yoon T.H. 1989. Otologic histopathology of Fabry's disease. The Annals of Otology, Rhinology, and Laryngology, 98(5): 359–363.
- Weidemann F., Breunig F., Beer M., Sandstede J., Turschner O., Voelker W., Ertl G., Knoll A., Wanner C., Strotmann J. 2003. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation, 108(11): 1299–1301.